Allotment of Securities

Ref: ISLL:CH:2026 Date: 17th September, 2026 To, To, The Manager, The Manager, Department of Corporate Services, Listing & Compliance Department, BSE Limited National Stock Exchange of India Limited Exchange Phiroze Jeejeebhoy Towers, Plaza, 5th Floor, Plot No. C-1, G- Block, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai - 400051 Scrip Code: 532305 Symbol: INDSWFTLAB Subject : Allotment of 70,00,000 Fully Convertible Warrants to an entity belonging to the ‘Promoter & Promoter Group’. Ref : Intimation as per Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Dear Sir/Ma’am, In accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations, 2015'), we wish to inform that the Preferential issue Committee of Board of Directors of the Company has, inter alia, considered and approved today i.e., Thursday 17th September, 2026 pursuant to Shareholders’ approval dated 5th August, 2026 and In-Principal approval received from the BSE Limited (‘BSE’) and National Stock Exchange of India Limited (‘NSE’) dated 16th September, 2026: - i. Allotment of 70,00,000 Fully Convertible Warrants (“Warrants”) at an issue price of Rs. 196/- per warrant (including premium of Rs. 186/- each), on preferential basis to the following entity upon receipt of 25% of the Warrant Issue Price i.e., Rs. 49/- per warrant, aggregating to Rs. 34,30,00,000/- (Rupees Thirty-Four Crore Thirty Lakhs Only) ("Warrant Subscription Price"): S. No. Name of the Allottee(s) Category No. of Warrants Allotted 1. Essix Biosciences Limited Promoter & Promoter Group 70,00,000 Total 70,00,000 The meeting of the Preferential Issue Committee of the Board of Directors commenced at 05:00 P.M. and concluded at 05:10 P.M. You are requested to kindly take the same on your records. Thanking You, Yours Faithfully, For Ind-Swift Laboratories Limited Pardeep Verma VP-Corporate Affairs & Company Secretary